Not all individuals with CLL demand therapy. Irrespective of all latest developments, the iwCLL even now suggests watchful observation for patients with asymptomatic illness.86 This recommendation is based on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F